24
Clinical Trials associated with FACE-CAR T(Chinese Academy of Sciences) / Not yet recruitingEarly Phase 1IIT A Single-arm, Open-label, Single-center Clinical Study: Safety, Tolerability and Preliminary Efficacy of Autologous Anti-CLL1/CLL1+CD33 CAR-T in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
/ Not yet recruitingEarly Phase 1IIT A single-arm, unblinded clinical study of safety and efficacy of autogenous CLL1 CAR T cells in patients with acute myeloid leukemia
/ Not yet recruitingEarly Phase 1IIT A single-arm, dose-escalation and dose-expansion phase I clinical study to evaluate the tolerability, safety and preliminary efficacy of BG1805 injection in the treatment of relapsed or refractory acute myeloid leukemia
Start Date08 May 2022 |
Sponsor / Collaborator- |
100 Clinical Results associated with FACE-CAR T(Chinese Academy of Sciences)
100 Translational Medicine associated with FACE-CAR T(Chinese Academy of Sciences)
100 Patents (Medical) associated with FACE-CAR T(Chinese Academy of Sciences)
100 Deals associated with FACE-CAR T(Chinese Academy of Sciences)